PMC4840419_01
Clinical course after second molecular relapse. The patient received the combination chemotherapy of tamibarotene and As2O3. He attained hematological CR and molecular CR on day 28 and on day 61, respectively. APL: acute promyelocytic leukemia, WBC: white blood cell, Plt: platelet.
gr1.jpg
PMC4840419_01_gr1.jpg
f0005
He achieved hematological and molecular CR on day 28 and on day 61, respectively (Fig. 1).